Tumor Delivery of Ultrasound Contrast Agents Using Shiga Toxin B Subunit
The present study demonstrates the targeting of ultrasound contrast agents to human xenograft tumors by exploiting the overexpression of the glycolipid Gb3 in neovasculature. To this end, microbubbles were functionalized with a natural Gb3 ligand, the B subunit of the Shiga toxin (STxB). The targeti...
Main Authors: | Olivier Couture, Estelle Dransart, Sabrina Dehay, Fariba Nemati, Didier Decaudin, Ludger Johannes, Mickael Tanter |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2011-03-01
|
Series: | Molecular Imaging |
Online Access: | https://doi.org/10.2310/7290.2010.00030 |
Similar Items
-
In Vivo Tumor Targeting by the B-Subunit of Shiga Toxin
by: Thomas Viel, et al.
Published: (2008-11-01) -
Shiga Toxin Uptake and Sequestration in Extracellular Vesicles Is Mediated by Its B-Subunit
by: Annie Willysson, et al.
Published: (2020-07-01) -
Do the A Subunits Contribute to the Differences in the Toxicity of Shiga Toxin 1 and Shiga Toxin 2?
by: Debaleena Basu, et al.
Published: (2015-04-01) -
Shiga Toxin—A Model for Glycolipid-Dependent and Lectin-Driven Endocytosis
by: Ludger Johannes
Published: (2017-10-01) -
Lipid reorganization induced by Shiga toxin clustering on planar membranes.
by: Barbara Windschiegl, et al.
Published: (2009-07-01)